Armata Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Armata Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.76M, a 5.61% increase year-over-year.
  • Armata Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$41.5M, a 0.39% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$40.9M, a 10.7% decline from 2022.
  • Armata Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$36.9M, a 55.1% decline from 2021.
  • Armata Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$23.8M, a 10.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$40.9M -$3.94M -10.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$36.9M -$13.1M -55.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$23.8M -$2.24M -10.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$21.6M -$1.84M -9.29% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 -$19.8M -$2.09M -11.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 -$17.7M -$1.5M -9.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 -$16.2M +$7.22M +30.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-25
2016 -$23.4M -$13.2M -129% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-14
2015 -$10.2M +$3.88M +27.5% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-27
2014 -$14.1M -$1.73M -13.9% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 -$12.4M Jan 1, 2013 Dec 31, 2013 10-K 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.